Bill > HB05270

This bill proposes to prohibit direct-to-consumer (DTC) prescription drug advertisements within the state. Direct-to-consumer advertising refers to pharmaceutical companies marketing prescription medications directly to patients through various media channels like television, print, online platforms, and other advertising mediums, rather than solely targeting healthcare professionals. By amending the state's general statutes, the bill aims to prevent pharmaceutical companies from creating and distributing advertisements that promote prescription drugs to consumers within the state. The goal appears to be protecting consumers from potentially misleading or persuasive marketing that might encourage individuals to request specific medications from their healthcare providers without fully understanding the medical implications, side effects, or appropriateness of the drug for their specific health condition. The bill represents a significant intervention in pharmaceutical marketing practices, seeking to limit the influence of drug company advertising on patient-physician interactions and medical decision-making.

Justice

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=HB05270&which_year=2025